BeOne Medicines (BEIGF) Share-based Compensation Growth (3y) (2018 - 2026)
Powered by 
Analysis
BeOne Medicines (BEIGF) Share-based Compensation Growth (3y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.53 Bn | 625.77 Bn | 17.26 Bn | -83.20% |
| 2 | AbbVie | 442.27 Bn | 435.70 Bn | 12.70 Bn | -2.48% |
| 3 | Merck | 366.81 Bn | 359.67 Bn | 12.21 Bn | 20.81% |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn | - |
| 5 | Pfizer | 159.37 Bn | 147.67 Bn | 10.94 Bn | 18.94% |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.12 Bn | 44.12 Bn | - | - |
| 8 | Incyte | 25.49 Bn | 20.95 Bn | 1.57 Bn | 7.25% |
| 9 | United Therapeutics | 21.55 Bn | 18.89 Bn | 683.80 Mn | - |
| 10 | BeOne Medicines | 2.48 Bn | -2.62 Bn | 1.53 Bn | 9.95% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.95% |
| Mar 31, 2026 | 17.87% |
| Dec 31, 2025 | 16.57% |
| Sep 30, 2025 | 21.67% |
| Jun 30, 2025 | 22.87% |
| Mar 31, 2025 | 13.35% |
| Dec 31, 2024 | 19.53% |
| Sep 30, 2024 | 19.58% |
| Jun 30, 2024 | 26.33% |
| Mar 31, 2024 | 24.60% |
| Dec 31, 2023 | 23.39% |
| Sep 30, 2023 | 24.05% |
| Jun 30, 2023 | 31.49% |
| Mar 31, 2023 | 25.34% |
| Dec 31, 2022 | 26.78% |
| Sep 30, 2022 | 28.53% |
| Jun 30, 2022 | 35.61% |
| Mar 31, 2022 | 35.43% |
| Dec 31, 2021 | 34.39% |
| Sep 30, 2021 | 38.71% |